Mark For: CAPC™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 97564180 |
Mark Literal Elements | CAPC |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Trademark |
Current Location | NEW APPLICATION PROCESSING 2022-08-29 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Crissa A. Cook |
Attorney Docket Number | 57738-US |
2019-07-26 | Date of First Use |
2022-04-18 | Date of Use In Commerce |
2022-08-25 | Application Filed |
2022-08-29 | Location: NEW APPLICATION PROCESSING |
2022-08-29 | Status: Live/Pending |
2022-08-29 | Status: New application will be assigned to an examining attorney approximately 6 months after filing date. |
2022-08-29 | Transaction Date |
Party: | Phoreus Biotechnology, Inc. |
Address | 22201 W. Innovation Drive Olathe, KANSAS UNITED STATES 66061 |
Legal Entity Type | Corporation |
Legal Entity State | KANSAS |
Application | 2022-08-25 | |
Drawing | 2022-08-25 | |
Specimen | 2022-08-25 |
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Preparations and substances for facilitating delivery of active substances, namely, a drug delivery agent in the form of peptide capsules, microspheres, or nanospheres for delivering nucleic acids, proteins, enzymes, small molecules, therapeutic drugs, organic compounds, plasmids, dyes, nutrients, minerals, colloidal metal, pesticides, insecticides, parasiticides, and fungicides to cells; Peptides for drug delivery, namely, drug delivery agents consisting of peptide capsules, microspheres, or nanospheres containing or attached to active substances that facilitate delivery of a wide variety of pharmaceutical or veterinary preparations; Carriers in the form of peptide capsules, microspheres, or nanospheres used as vehicles to deliver active substances in the nature of pharmaceutical or veterinary preparations; Diagnostic agents for medical or veterinary purposes, namely, diagnostic agents in the form of peptide capsules, microspheres, or nanospheres containing or attached to imaging agents for medical or veterinary purposes; Peptide-based preparations for destroying vermin; Fungicides; Herbicides; Imaging agents in the form of peptide capsules, microspheres, or nanospheres for medical and veterinary diagnostic purposes, namely, contrasting agents for ultrasound or near-infrared diagnostic imaging, diagnostic radiopharmaceutical agent for use in PET imaging, imaging agents for magnetic resonance imaging (MRI), radiopharmaceutical imaging agents for diagnosing and monitoring cancer |
GS0051 | Preparations and substances for facilitating delivery of active substances, namely, a drug delivery agent in the form of peptide capsules, microspheres, or nanospheres for delivering nucleic acids, proteins, enzymes, small molecules, therapeutic drugs, organic compounds, plasmids, dyes, nutrients, minerals, colloidal metal, pesticides, insecticides, parasiticides, and fungicides to cells; Peptides for drug delivery, namely, drug delivery agents consisting of peptide capsules, microspheres, or nanospheres containing or attached to active substances that facilitate delivery of a wide variety of pharmaceutical or veterinary preparations; Carriers in the form of peptide capsules, microspheres, or nanospheres used as vehicles to deliver active substances in the nature of pharmaceutical or veterinary preparations; Diagnostic agents for medical or veterinary purposes, namely, diagnostic agents in the form of peptide capsules, microspheres, or nanospheres containing or attached to imaging agents for medical or veterinary purposes; Peptide-based preparations for destroying vermin; Fungicides; Herbicides; Imaging agents in the form of peptide capsules, microspheres, or nanospheres for medical and veterinary diagnostic purposes, namely, contrasting agents for ultrasound or near-infrared diagnostic imaging, diagnostic radiopharmaceutical agent for use in PET imaging, imaging agents for magnetic resonance imaging (MRI), radiopharmaceutical imaging agents for diagnosing and monitoring cancer |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2022-08-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.